ibtimes psd2s-long-shadow-casts-doubt-over-us-fintech-security-1636713

Health experts sharply criticized the precautionary measure, citing a lack of data, while analysts expressed concern about the impact on vaccine uptake as the virus continues to spread. The rollout of the Oxford-AstraZeneca vaccine had been halted in several countries after reports of blood clots in some vaccinated people.

In response, AstraZeneca said that the figures published Monday 'were based on a pre-specified interim analysis with a data cut-off of 17 February.' Anthony Fauci, the NIAID is part of the National Institutes of Health.įauci told ABC News' 'Good Morning America' on Tuesday that the Oxford-AstraZeneca shot is 'likely a very good vaccine.' However, he added, the DSMB became concerned that the data in AstraZeneca's public statement 'were somewhat outdated and might, in fact, be misleading a bit.'

Led by White House chief medical advisor Dr. The NIAID said it was notified of the concerns late Monday, along with AstraZeneca and the Biomedical Advanced Research and Development Authority. 'We urge the company to work with the DSMB to review the efficacy data and ensure the most accurate, up-to-date efficacy data be made public as quickly as possible.' National Institute of Allergy and Infectious Diseases said in a statement. The Data Safety Monitoring Board 'expressed concern that AstraZeneca may have included outdated information from that trial, which may have provided an incomplete view of the efficacy data,' the U.S. Personal Loans for 670 Credit Score or Lower Personal Loans for 580 Credit Score or Lower Best Debt Consolidation Loans for Bad Credit

Ibtimes psd2s-long-shadow-casts-doubt-over-us-fintech-security-1636713